ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Manager, Quality Engineering at Crinetics Pharmaceuticals - ApplyBlast

Senior Manager, Quality Engineering

Crinetics Pharmaceuticals

4 months ago

3.2 on Glassdoor

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A Senior Manager, Quality Engineering (GMP) at Crinetics drives execution and continuous facilitation of the Quality Risk Management (QRM) program across manufacturing and commercial operations. The role involves partnering with cross-functional teams to proactively identify, assess, and manage risks throughout the product lifecycle while ensuring compliance with GMP regulations and global regulatory expectations. This position serves as a key operational leader and subject matter expert, supporting inspection readiness and quality system effectiveness.

Responsibilities

Lead day-to-day execution of the GMP Quality Risk Management program
Facilitate structured risk assessments with cross-functional subject matter experts
Embed risk-based decision making into product development and manufacturing
Ensure risks are appropriately documented and trended within QMS tools
Provide mentorship and guidance on QRM principles to junior team members

Skills

Qualifications

Bachelor's degree in ChemistryBachelor's degree in BiologyBachelor's degree in EngineeringLean Six Sigma CertificationSix Sigma Certification

About Crinetics Pharmaceuticals

crinetics.com

Headquarters

San Diego, California, United States

Company Size

201-500 employees

Founded

2008

View Profile

Crinetics Pharmaceuticals, now a Vertex Pharmaceuticals company, is a pharmaceutical company dedicated to discovering, developing, and commercializing treatments for endocrine diseases. Based in San Diego, CA, the company maintains a pipeline of novel therapies including Paltusotine (an oral SST2 agonist) and Atumelnant (an oral ACTH antagonist). Crinetics aims to be the premier endocrine-rooted global pharmaceutical company, focused on improving the lives of patients with endocrine disorders.